Australians battling with prostate cancer to benefit from new PBS listing

25 May 2023 - Australians battling prostate cancer that has spread past the prostate will soon benefit from subsidised medicine ...

Read more →

PBAC Public Summary Document - May 2023

24 May 2023 - The Public Summary Document of the PBAC's consideration of the interim report of the post-market review of ...

Read more →

New life changing treatment for dwarfism added to PBS

24 May 2023 - Children born with the most common form of dwarfism will have access to a new life ...

Read more →

Revolutionising MS treatment: new form of Tysabri recommended for PBS listing

24 May 2023 - The PBAC has recommended the listing of natalizumab (Tysabri) pre-filled syringe for subcutaneous injection on the PBS.  ...

Read more →

Is the quality of evidence in health technology assessment deteriorating over time? A case study on cancer drugs in Australia.

18 May 2023 - This study aimed to assess whether there have been changes in the quality of clinical evidence ...

Read more →

RACGP welcomes asthma puffer decision saving Aussie families time and money

15 May 2023 - The Royal Australian College of GPs (RACGP) has welcomed the PBAC's decision to remove limitations requiring ...

Read more →

Pharmacy Guild rebuked over scare campaign on medicine shortages

15 May 2023 - A long-time chair of the government’s independent pharmaceutical advisory body has rebuked the powerful pharmacy lobby ...

Read more →

PBAC dismisses Pharmacy Guild concerns on 60 day dispensing

12 May 2023 - The chair of the PBAC has dismissed concerns that 60 day dispensing will cause medicine shortages, ...

Read more →

Public Consultation: draft 2023-24 Cost Recovery Implementation Statement (CRIS) for listing medicines on the PBS and designated vaccines on the NIP

12 May 2023 - Consultation on the draft 2023-24 Cost Recovery Implementation Statement (CRIS) for listing medicines on the Pharmaceutical ...

Read more →

PBAC backs ongoing access to low-dose asthma puffer for Aussie kids

12 May 2023 - The independent, expert group advising the Australian Government on PBS medications has reviewed its recommendation to put ...

Read more →

Outcome in relation to fluticasone propionate – May 2023 PBAC intracycle meeting

12 May 2023 - The outcome for fluticasone propionate from the May 2023 PBAC meeting is now available. ...

Read more →

More medicine, for less

11 May 2023 - The Australian Government is making hundreds of medicines cheaper by allowing millions of Australians to buy two ...

Read more →

May 2023 updates from the Health Technology Assessment Policy and Methods Review Reference Committee

11 May 2023 - Information regarding the experts in HTA to support the HTA Review is now available. ...

Read more →

Reforming opioid dependence treatment access

10 May 2023 - In the 2023-24 Budget, the Australian Government committed $377.3 million over 4 years from 2023–24 (and $98.4 ...

Read more →

Recommendations made out-of-session by the PBAC between March 2023 and July 2023 meetings

10 May 2023 - Recommendations made out-of-session by the PBAC between its March 2023 and July 2023 meetings are now available. ...

Read more →